Alyeska Investment Group’s MDxHealth MDXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-70,293
Closed -$99.8K 629
2025
Q1
$99.8K Sell
70,293
-936,707
-93% -$1.69M ﹤0.01% 492
2024
Q4
$2.39M Hold
1,007,000
0.01% 452
2024
Q3
$2.09M Buy
+1,007,000
New +$2.73M 0.01% 418
2023
Q4
Sell
-279,555
Closed -$783K 612
2023
Q3
$783K Hold
279,555
0.01% 431
2023
Q2
$953K Sell
279,555
-320,445
-53% -$1.17M 0.01% 460
2023
Q1
$1.94M Buy
+600,000
New +$2.74M 0.02% 355

Other funds holding MDXH

Alyeska Investment Group's MDXH Position: Q2 2025 in Review

Alyeska Investment Group sold out of MDxHealth (MDXH) in Q2 2025, closing a stake of 70,293 shares — an estimated $99.8K sold.

Alyeska Investment Group first reported a position in MDXH in Q1 2023 and held it in 6 quarters. The position peaked at $2.39M in Q4 2024. 21 funds tracked by Wall St. Rank hold MDXH as of Q2 2025.

  • Alyeska Investment Group reported no remaining MDxHealth position as of Q2 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 70,293 MDxHealth shares in Q2 2025, an estimated $99.8K.
  • Alyeska Investment Group first reported a position in MDxHealth in Q1 2023 and held it in 6 quarters.
  • Alyeska Investment Group's MDxHealth position peaked at $2.39M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held MDxHealth as of Q2 2025.

Based on Alyeska Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.